Literature DB >> 11947463

Galactosylgalactosylglucosylceramide: Galactosyl hydrolase in normal human plasma and its absence in patients with fabry's disease.

C A. Mapes1, R L. Anderson, C C. Sweeley.   

Abstract

Entities:  

Year:  1970        PMID： 11947463     DOI： 10.1016/0014-5793(70)80151-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  5 in total

1.  Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

Authors:  R J Desnick; K J Dean; G Grabowski; D F Bishop; C C Sweeley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  [Electron microscopic observations in internal organs in morbus Fabry (author's transl)].

Authors:  J Roth; H Roth
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-05-05

3.  [Analytical study of Fabry's disease (author's transl)].

Authors:  J Roth; E Schulze; G Raabe; G Waldmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

4.  Hydrolysis of ceramide trihexoside by a specific -galactosidase from human liver.

Authors:  M W Ho
Journal:  Biochem J       Date:  1973-05       Impact factor: 3.857

5.  Heterozygote detection in angiokeratoma corporis diffusum (Anderson-Fabry disease). Studies on plasma, leucocytes, and hair follicles.

Authors:  M W Spence; A L Goldbloom; J K Burgess; D D'entremont; B A Ripley; K L Weldon
Journal:  J Med Genet       Date:  1977-04       Impact factor: 6.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.